Bill Status - Complete Bill History

Select Bill Type

Select Year

Select Session

Search Bills by:	Bill Quick Search:	Bill Tracking:
All Bills (House \| Senate) All Resolutions Subject Short Title Sponsor Date Introduced Code Affected All Same As Pending In Committee Reported From Committee Passed One Chamber Fiscal Notes Completed Legislation Actions by Governor View Public Comments	Enter Bill Number

	Legislative Session: 2026(RS)
LAST ACTION:	S To Finance 02/18/26
SUMMARY:	Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
LEAD SPONSOR:	Browning
SPONSORS:	Worrell, Burkhammer, Dean, Hillenbrand, Hite, Heckert
BILL TEXT: Bill Definitions	Engrossed Version - html \| pdf \| docx Introduced Version - html \| pdf \| docx
CODE AFFECTED:	§16 - 67 - 1 (New Code) §16 - 67 - 2 (New Code) §16 - 67 - 3 (New Code) §16 - 67 - 4 (New Code) §16 - 67 - 5 (New Code) §16 - 67 - 6 (New Code) §16 - 67 - 7 (New Code)
FISCAL NOTES:	Health, WV Department of
SUBJECT(S):	Health

ACTIONS:

	Description	Date	Journal Page
S	To Finance	02/18/26	11
S	Reported do pass, but first to Finance	02/18/26	11
S	To Health and Human Resources	01/30/26	4
S	To Health and Human Resources then Finance	01/30/26
S	Introduced in Senate	01/30/26	4
H	Communicated to Senate	01/29/26
H	Passed House (Roll No. 32)	01/29/26
H	Read 3rd time	01/29/26
H	On 3rd reading, Special Calendar	01/29/26
H	Read 2nd time	01/28/26
H	On 2nd reading, Special Calendar	01/28/26
H	Read 1st time	01/27/26
H	On 1st reading, Special Calendar	01/27/26
H	On 1st reading, Special Calendar	01/26/26
H	Do pass	01/23/26
H	Markup Discussion	01/22/26
H	To House Health and Human Resources	01/21/26
H	Introduced in House	01/21/26
H	To Health and Human Resources	01/21/26
H	Filed for introduction	01/21/26

Building House Bill 4626 PDF